← Browse by Condition
Medical Condition

pdl1 gene mutation

Total Trials
1
Recruiting Now
1
Trial Phases
Various
NCT06634199
Recruiting

Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

Enrollment
50 pts
Location
Spain
Sponsor
Fundación GECP
View Trial →